Gland Pharma Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: GLAND BSE: 543245

₹2899.40

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #17 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Gland Pharma Limited (this stock)	47,828	34.3	9.9%	46.3%	0.69%	66	37	50

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹44,651 Cr

EV / EBITDA

21.7x

EV / Sales

9.30x

Market cap / Sales

9.96x

Earnings yield

2.92%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 1,345 Cr, up 23.0% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 364 Cr, up 35.3% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	1,287	488	364	₹22.1100
March 31, 2026	1,262	565	420	₹25.5200
Dec. 31, 2025	1,178	412	308	₹18.6800
Sept. 30, 2025	1,074	409	302	₹18.3300
June 30, 2025	1,039	362	269	₹16.3400
March 31, 2025	1,030	391	290	₹17.6000
Dec. 31, 2024	1,011	394	295	₹17.9100
Sept. 30, 2024	1,063	380	282	₹17.1000
June 30, 2024	1,012	300	223	₹13.5300
March 31, 2024	1,175	433	321	₹19.5100
Dec. 31, 2023	1,098	372	277	₹16.8100
Sept. 30, 2023	1,011	347	258	₹15.6400
June 30, 2023	884	254	188	₹11.3900

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	1,345	1,368	1,238	1,157	1,094	1,074	1,076	1,121	1,061	1,222	1,141	1,052	919
Operating revenue	1,287	1,262	1,178	1,074	1,039	1,030	1,011	1,063	1,012	1,175	1,098	1,011	884
Other income	59	106	60	83	55	44	65	58	48	47	43	41	35
Operating expenses	813	754	756	699	680	636	620	699	718	742	728	664	625
Operating profit	474	508	422	375	359	394	391	364	294	433	369	347	259
Operating profit margin	36.8%	40.2%	35.8%	34.9%	34.5%	38.3%	38.7%	34.2%	29.0%	36.8%	33.7%	34.3%	29.3%
Depreciation	44	43	45	45	44	43	44	42	41	43	40	40	39
Interest	1	6	1	4	7	3	18	0	1	5	1	1	2
Exceptional items, gain / (loss)	—	—	-24	—	—	—	—	—	—	—	—	—	—
Profit before tax	488	565	412	409	362	391	394	380	300	433	372	347	254
Tax	123	144	105	107	93	101	99	98	77	111	95	90	66
Net profit	364	420	308	302	269	290	295	282	223	321	277	258	188
EPS	22.11	25.52	18.68	18.33	16.34	17.60	17.91	17.10	13.53	19.51	16.81	15.64	11.39
Net profit (TTM)	1,395	1,300	1,169	1,156	1,136	1,090	1,121	1,103	1,079	1,043	801	752	734
EPS (TTM)	84.64	78.87	70.95	70.18	68.95	66.14	68.05	66.95	65.49	63.35	48.65	45.66	44.57

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	4,552	1,748	1,300
March 31, 2025	4,116	1,466	1,090
March 31, 2024	4,167	1,405	1,043
March 31, 2023	3,617	1,048	776

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Total income (before exceptional items)	8.0%	—	4,856^†	4,331^†	4,334^†	3,857^†	4,625^†
Operating revenue	8.0%	—	4,552	4,116	4,167	3,617	4,401^†
Other income	—	—	304^†	215^†	167^†	240^†	224^†
Operating expenses	—	—	2,889^†	2,674^†	2,759^†	2,598^†	2,890^†
Operating profit	17.8%	—	1,663^†	1,443^†	1,409^†	1,019^†	1,511^†
Operating profit margin	—	—	36.5%^†	35.0%^†	33.8%^†	28.2%^†	34.3%^†
Depreciation	—	—	176^†	169^†	162^†	147^†	110^†
Interest	—	—	18^†	23^†	8^†	7^†	5^†
Exceptional items, gain / (loss)	—	—	-24^†	0^†	0^†	-56^†	0^†
Profit before tax	18.6%	—	1,748	1,466	1,405	1,048	1,619^†
Tax	—	—	449^†	376^†	362^†	273^†	407^†
Net profit	18.8%	—	1,300	1,090	1,043	776	1,212^†
EPS	18.7%	—	78.87^†	66.14^†	63.35^†	47.13^†	73.83^†

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Operating margin	36.5%^†	35.0%^†	33.8%^†	28.2%^†	34.3%^†
EBIT margin	38.8%^†	36.2%^†	33.9%^†	29.2%^†	36.9%^†
PBT margin	38.4%	35.6%	33.7%	29.0%	36.8%^†
Net margin	28.5%	26.5%	25.0%	21.5%	27.5%^†
Interest coverage	97.74x^†	65.18x^†	180.20x^†	142.41x^†	309.98x^†
Dividend payout	22.8%^†	30.2%^†	0.0%^†	0.0%^†	0.0%^†
Earnings retention	77.2%^†	69.8%^†	100.0%^†	100.0%^†	100.0%^†
Current ratio	10.15x	11.01x	—	—	—
Quick ratio	8.15x	8.62x	—	—	—
Debt to equity	0.00x	0.00x	—	—	—
Return on equity	12.0%	11.2%	—	—	—
Return on assets	11.2%	10.5%	—	—	—
Return on capital employed	16.1%^†	15.0%^†	—	—	—
Asset turnover	0.39x	0.39x	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	1,135	-96	-316	218	917
March 31, 2025	1,074	1,578	-340	135	939
March 31, 2024	1,136	-2,924	-7	234	902
March 31, 2023	368	1,208	15	221	147
March 31, 2022	791	-1,010	35	511	280

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	11,607	10,810	10,794	0	0	6,422	633	3,178	1,684	1,265
March 31, 2025	10,422	9,755	9,739	1	1	5,767	524	2,433	1,736	1,254
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.